Medical Health & Life Science Research News

The nerve repair and regeneration market is expected to reach USD 10.59 billion by 2022 scrutinized in new research

The nerve repair and regeneration market is expected to reach USD 10.59 billion by 2022 scrutinized in new research

According to a new market research report "Nerve Repair and Regeneration Market by Application (Neurorrhaphy, Nerve Grafting, Stem Cell Therapy, Neurostimulation Surgery), Products (Biomaterials, Nerve Conduits, Nerve Protectors, Nerve Wraps, Neurostimulation Devices - Global Forecast to 2022", published by MarketsandMarkets™, the Market is expected to reach USD 10.59 Billion by 2022 from USD 5.79 Billion in 2017, at a CAGR of 12.9%.

- Advertising -

Browse 83 Market Data Tables and 31 Figures spread through 124 Pages and in-depth TOC on "Nerve Repair and Regeneration Market"

www.marketsandmarkets.com/Market-R…n-market-883.html

Increasing number of neurological disorders, rising geriatric population, and technological advancements are the major factors that are driving the growth of this market.

Download PDF Brochure @ www.marketsandmarkets.com/pdfdownl…m_campaign=PaidPR    

By neurostimulation and neuromodulation device product, the internal neurostimulation device segment is expected to dominate the market in 2017 

On the basis of neurostimulation and neuromodulation device product is sub segmented into internal neurostimulation device and external neurostimulation device. The internal neurostimulation device segment is expected to account for the largest share of this market in 2017.

This growth can be attributed to minimally invasive techniques and increasing number of people suffering from back surgery syndrome which drives this segment.

- Advertising -

By end user, the hospitals and clinics segment is expected to dominate the market in 2017 

In the end user, the nerve repair and regeneration market is segmented into hospitals and clinics, and ambulatory surgical centres. The hospitals and clinics sengment is expected to account for the largest share in the market.

The growth is primarily attributed to the increasing incidence of neurological incidence and growth in the number of hospitals in emerging countries.

Asia offers lucrative growth opportunities 

By region, the global nerve repair and regeneration market is segmented into North America, Europe, Asia, and the Rest of the World (RoW). While North America holds the largest share of the market in 2017, Asia is expected to register the highest CAGR during the forecast period.

The presence of emerging economies like China and India; the large population; growth in the number of hospitals, and increasing neurological disorder in the region are some major factors driving the high growth of this regional segment.

Some of the major players operating in the nerve repair and regeneration market are AxoGen (US), Baxter (US), Boston Scientific (US), LivaNova (UK), Integra LifeSciences (US), Medtronic (US), Abbott Laboratories (US), Stryker (US), Nevro (US), Polyganics (Netherlands), and Nuvectra (US).

Access Report @ www.marketsandmarkets.com/speaktoa…m_campaign=PaidPR

Study Coverage: 

The report segments this market based on product, application, end user, and region. The market study covers the global nerve repair and regeneration market from 2015 to 2022 and provides details of the factors influencing the market at both macro and micromarket.

The report also provides a detailed overview of the major drivers, opportunities, restrains, current market challenges, and strategies impacting the nerve repair and regeneration market along with the estimates and forecasts of the revenue and market share analysis.

News From

MarketsandMarkets™ - Business ResearchMarketsandMarkets™
Category: Market Research Publishers and RetailersCompany profile: MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 5000 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions. Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth ...